Entity usage

Showing below up to 50 results in range #101 to #150.

101. Coefficients of agreement for fixed observers: Label: en
102. Estimating the variance of cancer prevalence from population-based registries: Label: en
103. Can one assess whether missing data are missing at random in medical studies?: Label: en
104. Designs in partially controlled studies: messages from a review: Label: en
105. Structural mean models for compliance analysis in randomized clinical trials and the impact of errors on measures of exposure: Label: en
106. Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods: Label: en
107. Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis: Label: en
108. Uses and limitations of randomization-based efficacy estimators: Label: en
109. Multicentre trials: a US regulatory perspective: Label: en
110. Randomization-based nonparametric methods for the analysis of multicentre trials: Label: en
111. Bayesian analysis of multicentre trial outcomes: Label: en
112. The design of multicentre trials: Label: en
113. Bayesian spatio-temporal analysis of joint patterns of male and female lung cancer risks in Yorkshire (UK): Label: en
114. Methods for detecting disease clustering, with consideration of childhood leukaemia: Label: en
115. Surveillance of individual level disease maps: Label: en
116. Disease mapping in veterinary epidemiology: a Bayesian geostatistical approach: Label: en
117. Segmental modeling of changing viral load to assess drug resistance in HIV infection: Label: en
118. Markov transition models for binary repeated measures with ignorable and nonignorable missing values: Label: en
119. Applying artificial neural networks to the diagnosis of organic dyspepsia: Label: en
120. Mendelian randomization as an instrumental variable approach to causal inference: Label: en
121. A comparison of imputation techniques for handling missing predictor values in a risk model with a binary outcome: Label: en
122. Sensitivity analysis after multiple imputation under missing at random: a weighting approach: Label: en
123. Evaluation of software for multiple imputation of semi-continuous data: Label: en
124. Multiple imputation of discrete and continuous data by fully conditional specification: Label: en
125. Multiple imputation: current perspectives: Label: en
126. Comparison of subject-specific and population averaged models for count data from cluster-unit intervention trials: Label: en
127. A weighted zero-inflated Poisson model for estimation of recurrence of adenomas: Label: en
128. Model-based or algorithm-based? Statistical evidence for diabetes and treatments using gene expression: Label: en
129. Bayesian methods for the analysis of inequality constrained contingency tables: Label: en
130. Wei, Lin and Weissfeld's marginal analysis of multivariate failure time data: Label: en
131. Factor analysis model evaluation through likelihood cross-validation: Label: en
132. Developing international consensus on measures of improvement for patients with myositis: Label: en
133. Assessing disease progression using a composite endpoint: Label: en
134. Classifying radiographic progression status in early rheumatoid arthritis patients using propensity scores to adjust for baseline differences: Label: en
135. Mean changes versus dichotomous definitions of improvement: Label: en
136. Estimating causal effects from multiple cycle data in studies of in vitro fertilization: Label: en
137. Statistical models for human fecundability: Label: en
138. Cervical mucus symptom and daily fecundability: first results from a new database: Label: en
139. Heterogeneity in fecundability studies: issues and modelling: Label: en
140. Design and analysis of time-to-pregnancy: Label: en
141. Analysis of repeated pregnancy outcomes: Label: en
142. Methodologic issues in the design and analysis of epidemiologic studies of pregnancy outcome: Label: en
143. Outdoor NO_x and stroke mortality: adjusting for small area level smoking prevalence using a Bayesian approach: Label: en
144. Optimal vaccination schemes for epidemics among a population of households, with application to variola minor in Brazil: Label: en
145. Joint spatial analysis of gastrointestinal infectious diseases: Label: en
146. Assessing surveillance using sensitivity, specificity and timeliness: Label: en
147. Online updating of space-time disease surveillance models via particle filters: Label: en
148. Virtual surveillance of communicable diseases: a 20-year experience in France: Label: en
149. Bayesian spatio-temporal analysis of joint patterns of male and female lung cancer risks in Yorkshire (UK): Label: en
150. Methods for detecting disease clustering, with consideration of childhood leukaemia: Label: en